论文部分内容阅读
Objective: To test the expression of serine/arginine rich splicing factor 1 (SRSF1) and survivin[poptosis inhibiting factor (survivin)]in prostate cancer organizations,and study their correlation with the pathological features of prostate cancer,thus put forward the new targets in the treatment of prostate cancer.